Emergent BioSolutions Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Emergent BioSolutions Inc. (EBS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-190.60-760.50-211.60219.50305.1054.5062.70
Depreciation & Amortization108.80125.10143.30123.80118.00113.7062.20
Deferred Income Tax-5.50-8.90-28.6046.00-2.40-1.108.60
Stock Based Compensation18.0023.1045.1042.4051.800.000.00
Change in Working Capital88.70-70.30-2.10-145.00-13.00-46.60-119.10
Change in Accounts Receivable-24.40-21.60118.10-16.2027.500.000.00
Change in Inventory-24.500.60-57.10-66.60-66.900.000.00
Change in Accounts Payable-33.0010.60-14.00-1.6028.300.000.00
Change in Other Working Capital170.6013.409.502.503.400.000.00
Other Operating Activities39.3013.409.5033.7074.8038.504.20
Net Cash from Operating Activities58.70-206.30-34.10320.20536.00188.0041.80
Investing Activities
Capital Expenditures-22.90-51.60-115.80-224.10141.0086.90-72.10
Acquisitions0.00270.402.602.9021.7014.80-827.70
Sales/Maturities of Investments0.00-6.30-243.700.00-10.000.000.00
Other Investing Activities148.10-6.30-21.800.000.000.002.60
Net Cash from Investing Activities125.20212.30-381.30-224.10-151.00-96.90-897.20
Financing Activities
Debt Repayment-198.40-563.40-33.80-35.90-395.50-116.30-2.80
Common Stock Issued9.308.40-82.1015.9031.600.00-0.10
Common Stock Repurchased0.00-2.50-82.10-119.80-13.800.000.00
Other Financing Activities-0.90-2.50-5.90-1.20-16.60-57.80-22.30
Net Cash from Financing Activities-190.00-535.70481.20-141.0069.50-35.90788.70
Summary
Effect of Forex Changes on Cash0.00-1.200.50-0.30-1.000.40-0.20
Net Change in Cash-6.10-529.7065.80-45.20453.5055.60-66.70
Cash at Beginning of Period111.70642.60576.30621.50168.00112.40179.30
Cash at End of Period105.60111.70642.60576.30621.50168.00112.40
Free Cash Flow35.80-257.90-149.9096.10395.00101.10-30.30
Supplemental Disclosures
Interest Paid64.0068.3033.0030.4021.0034.5010.20
Income Taxes Paid26.5052.806.2071.60109.3030.8014.00